Iloprost for chronic thromboembolic pulmonary hypertension (Q44957846)

7 December 2017

Iloprost for chronic thromboembolic pulmonary hypertension (English)

1 reference

Chronic Thromboembolic Pulmonary Hypertension

7 December 2017

0 references

1 reference

Roig Figueroa V

1

1 reference

7 December 2017

Herrero Pérez A

2

1 reference

7 December 2017

de la Torre Ferrera N

3

1 reference

7 December 2017

Hernández García E

4

1 reference

7 December 2017

Aller Alvarez JL

5

1 reference

7 December 2017

Para Cabello J

6

1 reference

7 December 2017

1 July 2004

1 reference

Archivos de Bronconeumologia

7 December 2017

1 reference

7 December 2017

40

1 reference

7 December 2017

7

1 reference

7 December 2017

326-328

1 reference

Chronic thromboembolic pulmonary hypertension

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Pulmonary endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Long-term results after thromboendarterectomy for chronic pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Right ventricular pathology in chronic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension Without Major Vessel Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2804%2975533-7

7 January 2021

10.1016/S0300-2896(04)75533-7

Identifiers

DOI

1 reference

7 December 2017

1 reference